SCHEMBL855574

SCHEMBL855574

CCCCOC(=O)C(N)CCCN

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 2/20 0.47
DPP7 Q9UHL4 4/20 0.46
DPP8 Q6V1X1 2/20 0.46
DPP9 Q86TI2 2/20 0.46
DPP4 P27487 1/20 0.46
ALDH1A1 P00352 1/20 0.45
GNAI3 P08754 1/20 0.45
GNAO1 P09471 1/20 0.45
GNAI1 P63096 1/20 0.45
GSR P00390 1/20 0.42
ATM Q13315 1/20 0.42
TLR2 O60603 2/20 0.41
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
RRM1 P23921 1/20 0.40
SLC15A1 P46059 1/20 0.40
HCAR2 Q8TDS4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19547625 1.00 NOD1 (0.47) NOD1DPP7DPP8DPP9DPP4
SCHEMBL2494020 0.95 GNAI3 (0.51) NOD1DPP7DPP8DPP9DPP4
SCHEMBL856465 0.95 GNAI3 (0.51) NOD1DPP7DPP8DPP9DPP4
SCHEMBL5946309 0.95 NOD1 (0.52) NOD1DPP7DPP8DPP9DPP4
SCHEMBL5946307 0.95 NOD1 (0.52) NOD1DPP7DPP8DPP9DPP4
SCHEMBL19547636 0.93 NOD1 (0.54) NOD1DPP7DPP8DPP9DPP4
Hydrochloric Acid SCHEMBL10580924 0.93 GNAI3 (0.50) NOD1DPP7DPP8DPP9DPP4
SCHEMBL19547633 0.93 NOD1 (0.54) NOD1DPP7DPP8DPP9DPP4
Hydrochloric Acid SCHEMBL9537364 0.93 GNAI3 (0.50) NOD1DPP7DPP8DPP9DPP4
SCHEMBL14935740 0.93 GNAI3 (0.54) NOD1DPP7DPP8DPP9DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2976349-A1 A PROCESS FOR THE FUNCTIONALIZATION OF A SURFACE FZMB GmbH Forschungszentrum für Medizintechnik und Biotechnologie (DE) 2016-01-27 EP disclosed
WO-2014147168-A1 A PROCESS FOR THE FUNCTIONALIZATION OF A SURFACE FZMB GMBH FORSCHUNGSZENTRUM FÜR MEDIZINTECHNIK UND BIOTECHNOLOGIE (DE) 2014-09-25 WO disclosed
EP-2432760-A1 BRIDGED SPIRO [2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS Actelion Pharmaceuticals Ltd. (CH) 2012-03-28 EP disclosed
WO-2010134014-A1 BRIDGED SPIRO [2.4] HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-11-25 WO disclosed
EP-2252576-A2 SELECTIVE POLY-N-SUBSTITUTED GLYCINE ANTIBIOTICS Northwestern University (US) 2010-11-24 EP disclosed
WO-2009105167-A2 SELECTIVE POLY-N-SUBSTITUTED GLYCINE ANTIBIOTICS NORTHWESTERN UNIVERSITY (US) 2009-08-27 WO disclosed
EP-1453829-A1 SULFONAMIDO SUBSTITUTED IMIDAZOPYRIDINES 3M Innovative Properties Company (US) 2004-09-08 EP disclosed
EP-1451187-A1 AMIDE SUBSTITUTED IMIDAZOPYRIDINES 3M Innovative Properties Company (US) 2004-09-01 EP disclosed
EP-1451186-A2 UREA SUBSTITUTED IMIDAZOPYRIDINES 3M Innovative Properties Company (US) 2004-09-01 EP disclosed
EP-1343783-A2 SUBSTITUTED IMIDAZOPYRIDINES 3M Innovative Properties Company (US) 2003-09-17 EP disclosed
WO-2003050119-A2 UREA SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 WO disclosed
WO-2003050118-A1 AMIDE SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 WO disclosed
WO-2003050117-A1 SULFONAMIDO SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 WO disclosed
WO-2002046194-A2 SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-06-13 WO disclosed